National Health Investors (NHI) Capital Expenditures (2009 - 2026)

National Health Investors' Capital Expenditures history runs 18 years deep, the most recent figure standing at $105.5 million for Q1 2026.

• Quarterly Capital Expenditures rose 41.63% year-over-year to $105.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $305.1 million (up 43.49% YoY) and the FY2025 annual result came in at $274.1 million, up 98.42% from the prior year.
• Capital Expenditures was $105.5 million for Q1 2026 at National Health Investors, down from $143.1 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $143.1 million in Q4 2025 and bottomed at -$35.5 million in Q3 2023.
• A 5-year average of $43.2 million and a median of $35.5 million in 2023 frame the typical range for Capital Expenditures.
• Annual changes were most pronounced in 2022 — Capital Expenditures soared 8607.14% — and 2023, when it plunged 716.51%.
• National Health Investors' Capital Expenditures stood at $5.8 million in 2022, then soared by 508.33% to $35.5 million in 2023, then jumped by 261.28% to $128.3 million in 2024, then gained by 11.56% to $143.1 million in 2025, then retreated by 26.28% to $105.5 million in 2026.
• Business Quant data shows NHI's Capital Expenditures at $105.5 million in Q1 2026, $143.1 million in Q4 2025, and $56.5 million in Q2 2025.